Riskpilot← Back to searchSign inGet full accessSinven AB
ABActiveOrg 5592704752Teknologgatan 8 CGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
+87% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -2K
+72% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +87% |
| Net profit | SEK -2K | +72% |
| Total assets | SEK 32K | -63% |
| Equity | SEK 32K | -7% |
| Employees | 0 | — |
Legal name
Sinven AB
Org number
5592704752
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten ämnar bedriva hälsofrämjande och förebyggande vård i form av hälsokontroller och personlig läkarkontakt. Därtill även tillhandahålla sjukvårdsmaterial.
Address
Teknologgatan 8 C
Email
fredrik.vernet@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 736 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | 68 | −25 | −15 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 68 | −25 | −15 | −2 |
| Net financials | −2 | −7 | 8 | 0 |
| Profit before tax | 66 | −33 | −7 | −2 |
| Tax | −18 | −0 | −0 | — |
| Net profit | 48 | −33 | −7 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 205 | 10 | 85 | 32 |
| Equity | 73 | 40 | 34 | 32 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 132 | 31 | 51 | 0 |
| Total debt | 132 | 31 | 51 | — |
EBITDA margin
-201600.0%
This company
15.8%
Market median
-1276049% vs market
20212024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212024
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20212024
Net profit margin
-196300.0%
This company
8.1%
Market median
-2423557% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sinven AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Khushi Khushdeep Singh | Deputy Board Member | 0 companies |
| Kjell Erland Vernet | Deputy Board Member | 0 companies |
| Fredrik Erik Olof Vernet | Chairman | 0 companies |
| Bikramjit Singh | Board of Directors | 0 companies |